DeCODE And SGENE Consortium Discover Deletions In The Human Genome Linked To Risk Of Schizophrenia

In a major paper published in the online edition of the journal Nature, scientists from deCODE genetics (Nasdaq: DCGN) and the University of Iceland, along with academic colleagues from the deCODE-led European SGENE consortium, China and the United States, report the discovery of three rare deletions in the human genome that confer risk of schizophrenia.

More: continued here

Filed under: Clinical Trials on July 31st, 2008